Chairman since 2015, director since 2010.
Carl Borrebaeck is a professor at the Department of Immunotechnology and program director of the CREATE translational cancer research center at Lund University. He is an entrepreneur and founded SenzaGen AB and several other life science companies, including Immunovia AB and BioInvent International AB. He is also a founding mentor for the Nordic Mentor Network for Entrepreneurship (NOME), a member of the Royal Swedish Academy of Engineering Sciences (IVA) and a former vice-chancellor at Lund University. Carl has won a number of awards for his entrepreneurship and groundbreaking research, including AkzoNobel’s Science Prize in 2009 and the Biotech Builder Award in 2017.
Education: Professor of Immunotechnology, DSc major in molecular immunology, MSc in Chemical Engineering, MSc in Life Science.
Other appointments: Chariman of Immunovia AB, PainDrainer AB and CB Ocean Capital AB. Board member of Alligator Bioscience AB and Scandion A/S.
Shareholding: 1 698 571 shares (privately and through related parties).
Independance: Independent in relation to the company, the company’s senior executives and major shareholders of the company.